NIH-funded research R21 grant

Understanding cognitive disabilities in Down syndrome

Official title: A new approach to understanding cognitive disabilities in Down syndrome

Funded at University of Colorado Denver · NIH-10725562 · Data updated 2026-11-12

This study is looking at how changes in brain signaling might affect thinking skills in people with Down syndrome, using a mouse model to help understand the underlying brain processes, so we can learn more about the challenges they face.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startSeptember 19, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$429,000
NIH project number1R21NS133681-01
Project IDNIH-10725562 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Down syndrome, particularly those experiencing cognitive disabilities.

Less likely to help

Patients without Down syndrome or those who do not exhibit cognitive disabilities may not benefit from this research.

What this research studies

This research investigates the cognitive disabilities associated with Down syndrome, which is caused by an extra copy of chromosome 21. It focuses on the GABAergic hypothesis, which suggests that changes in GABA signaling during early brain development may lead to cognitive impairments. Using advanced techniques like two-photon microscopy and electrophysiology, the research aims to uncover the cellular and synaptic mechanisms that affect brain function in individuals with Down syndrome. By studying a mouse model that mimics human Down syndrome, the researchers hope to gain insights into the neurobiological factors contributing to these cognitive challenges.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies to improve cognitive function in individuals with Down syndrome.

How similar studies have gone: Previous research has shown promise in understanding cognitive disabilities through similar neurobiological approaches, but this specific investigation into the GABAergic hypothesis is relatively novel.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Oh, Won Chan — University of Colorado Denver
  • Study coordinator: Oh, Won Chan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.